课题基金 / 基金详情

Development of a Porcine Model of Carbon Monoxide Poisoning to Evaluate Cardiac and Mitochondrial Dysfunction

Development of a Porcine Model of Carbon Monoxide Poisoning to Evaluate Cardiac and Mitochondrial Dysfunction
开发一氧化碳中毒猪模型以评估心脏和线粒体功能障碍
批准号:
10063393
负责人:
DAVID H JANG
金额:
$7.48万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-03 至 2022-07-31
关键词:
AcuteAddressAffectAirAnatomyAnimal ModelAnimal Testing AlternativesAnimalsAreaAwardBiochemicalBioenergeticsBiological MarkersBiologyBiomedical ResearchCanis familiarisCarbon MonoxideCarbon Monoxide PoisoningCardiacCardiovascular systemCase StudyCathetersCause of DeathCessation of lifeCitiesClinicalComplicationConsequentialismCritical IllnessDataDepartment chairDetectionDevelopmentDiagnosticDiseaseDisease modelDomestic PigDoseDrosophila genusElectron TransportEmergency department visitEnsureEnvironmentEquipmentExhibitsExposure toFamily suidaeFire - disastersFunctional disorderFundingGasesGeneticGoalsHeart AbnormalitiesHeart InjuriesHospital CostsHumanHuman BiologyHyperbaric OxygenHyperbaric OxygenationHyperbaric TherapyImpairmentInjuryInvestigationIsofluraneKnowledgeMapsMeasurementMeasuresMedical SocietiesMedicineMentorsMetabolic BiotransformationMetabolic PathwayMethodsMitochondriaModelingMolecularMorbidity - disease rateMyocardial dysfunctionNational Heart, Lung, and Blood InstituteNervous System TraumaNeurologicNon-Rodent ModelOrganismPathway interactionsPatientsPhenotypePhysiologic intraventricular pressurePhysiologicalPhysiologyPoisoningReactive Oxygen SpeciesReportingResearchResearch PersonnelResearch SupportResourcesRespirationRetrospective StudiesRodentSourceSpecificitySuicide attemptSupportive careSurvivorsSus scrofaSystemTechniquesTestingThe SunTherapy Clinical TrialsTimeToxic effectToxicologyTrainingTranslatingTubeUnited StatesWorkXenobioticsZebrafishbasecareerclinical applicationclinically relevantdisabilitydosageendotrachealexperienceheart functionhuman diseaseimprovedin vivoinnovationlost earningmitochondrial dysfunctionmortalitymouse modelnew therapeutic targetnonhuman primatenovel strategiesnovel therapeuticsorgan injurypreclinical trialpressureprotein expressionresponseskillsstandard caresuccesstranslational model

项目摘要

项目成果

DAVID H JANG的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Carbon monoxide (CO) is a colorless and odorless gas that is an important cause of poisoning annually with an estimated 50,000 emergency department visits occurring in the US and it is a leading cause of poisoning death globally. Various sources include faulty heat generators, suicidal attempts and fires. It is estimated that CO poisoning in the US results in over $1 billion annually related to hospital costs and lost earnings. CO poisoning has high mortality and morbidity with effects at the cardiovascular and neurologic system. The most serious complication of consequential CO exposure is delayed neurological sequela which occurs in up to 50% of survivors. However, the cardiac sequalae is less defined as well as the underlying cellular dysfunction that may occur. Our own work demonstrates that there are alterations in mitochondrial function (both bioenergetic and dynamic) in CO poisoning. The standard treatment for CO poisoning recommended by the Undersea & Hyperbaric Medical Society is hyperbaric oxygen (HBO) therapy. At this time, both diagnostics and treatments are aimed at early supportive care and select use of hyperbaric therapy. There is significant debate with currently available biomarkers and treatment for CO poisoning requiring a new approach to therapy that is mechanism-driven. Based on these existing gaps, there are ongoing investigations for improved treatment based primarily on small animal studies. However, many agencies that oversee toxicological testing require use of both rodent and non-rodent species which is lacking at this time. There is a paucity of large animal models to study both cellular dysfunction and potential therapy in CO poisoning. The primary limitations that this R03 proposal seeks to address are the following: (1) limited mechanistic understanding at a cellular level with regard to mitochondrial function (bioenergetics and dynamics); (2) the adverse cardiovascular effects of CO poisoning and the underlying cellular dysfunction that may occur; (3) the lack of adequate large animal models that more closely mimic human physiology. We propose to develop a large animal model of CO poisoning using the domestic pig (Sus scrofa domesticus). The pig may be considered a translational model of biomedical research because of anatomical, physiological and biochemical similarity to humans. This R03 proposal is strongly supported by preliminary data and feasibility that will ensure success. The PI (Jang) currently holds a NHLBI K08 award and will specifically leverage his K-supported research skills and techniques focused in the area of mitochondrial medicine with the full support of both his departmental chair (Ben Sun, MD) and K08 mentor (Todd Kilbaugh, MD) along with the outstanding environment that incorporates state-of-the-art equipment. The data and methods obtained with this R03 award will allow the PI to submit a competitive R01 as an ESI.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Use of Blood Cells and Optical Cerebral Complex IV Redox States in a Porcine Model of CO Poisoning with Evaluation of Mitochondrial Therapy
  • 批准号:
    10734741
  • 项目类别:
  • 资助金额:
    $70.98万
  • 财政年份:
    2023
  • 负责人:
    DAVID H JANG
  • 依托单位:
The Use of Blood Cells as a Biomarker in a Porcine Model of CO Poisoning with Evaluation of an Engineered Succinate-Prodrug
  • 批准号:
    10276252
  • 项目类别:
  • 资助金额:
    $69.73万
  • 财政年份:
    2021
  • 负责人:
    DAVID H JANG
  • 依托单位:
Mitochondrial-Directed Therapy in Carbon Monoxide Poisoning
  • 批准号:
    10264056
  • 项目类别:
  • 资助金额:
    $20.78万
  • 财政年份:
    2020
  • 负责人:
    DAVID H JANG
  • 依托单位:
Development of a Porcine Model of Carbon Monoxide Poisoning to Evaluate Cardiac and Mitochondrial Dysfunction
  • 批准号:
    10228097
  • 项目类别:
  • 资助金额:
    $7.5万
  • 财政年份:
    2020
  • 负责人:
    DAVID H JANG
  • 依托单位:
海外基金